Forte Biosciences (FBRX) News Today $11.48 +0.92 (+8.71%) Closing price 04:00 PM EasternExtended Trading$11.47 -0.01 (-0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease SymposiumSeptember 15 at 10:07 AM | finance.yahoo.comShort Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Declines By 21.2%September 11, 2025 | marketbeat.comWe're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash WiselySeptember 11, 2025 | finance.yahoo.comFred Alger Management LLC Has $7.07 Million Stock Holdings in Forte Biosciences, Inc. $FBRXSeptember 11, 2025 | marketbeat.comForte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Down 21.2% in AugustSeptember 11, 2025 | americanbankingnews.comStock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)September 5, 2025 | marketbeat.comForte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX)August 23, 2025 | marketbeat.comGuggenheim Upgrades Forte Biosciences (NASDAQ:FBRX) to Strong-BuyAugust 22, 2025 | marketbeat.comForte Biosciences Reports Q2 2025 Financial ResultsAugust 19, 2025 | msn.comGuggenheim Initiates Coverage of Forte Biosciences (FBRX) with Buy RecommendationAugust 19, 2025 | msn.comForte Biosciences initiated with a Buy at GuggenheimAugust 18, 2025 | msn.comForte Biosciences initiated with a Buy at Guggenheim on FB102 potentialAugust 18, 2025 | msn.comForte Biosciences (NASDAQ:FBRX) Issues Quarterly Earnings Results, Beats Estimates By $0.25 EPSAugust 18, 2025 | marketbeat.comForte Biosciences' (FBRX) "Buy" Rating Reiterated at Chardan CapitalAugust 17, 2025 | marketbeat.comForte Biosciences (NASDAQ:FBRX) Raised to "Hold" at Wall Street ZenAugust 17, 2025 | marketbeat.comThis Forte Biosciences Insider Increased Their Holding By 273% Last YearAugust 15, 2025 | finance.yahoo.comForte Biosciences Announces Q2 2025 Results and TrialsAugust 15, 2025 | msn.comForte Biosciences reports Q2 EPS (96c), consensus ($1.11)August 15, 2025 | msn.comForte Biosciences (FBRX) to Release Earnings on WednesdayAugust 7, 2025 | marketbeat.comForte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)July 24, 2025 | marketbeat.comForte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants - NasdaqJune 27, 2025 | nasdaq.comForte Biosciences Announces Pricing of $75 Million Public Offering - Business WireJune 26, 2025 | businesswire.comForte Biosciences Inc News (FBRX) - Investing.comJune 26, 2025 | investing.comForte Biosciences stock falls after pricing capital raise of $75M via securities offeringJune 25, 2025 | msn.comForte Biosciences Announces Pricing of $75 Million Public OfferingJune 24, 2025 | businesswire.comForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study - MorningstarJune 24, 2025 | morningstar.comMForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study - NasdaqJune 24, 2025 | nasdaq.comForte Biosciences announces data from trial in celiac disease for FB102June 24, 2025 | finance.yahoo.comForte Biosciences Shares Fall After Proposed Public OfferingJune 24, 2025 | marketwatch.comForte Biosciences launches public offeringJune 24, 2025 | msn.comForte Biosciences Announces Proposed Public OfferingJune 24, 2025 | businesswire.comForte Biosciences (NASDAQ:FBRX) Earns Buy Rating from Chardan CapitalJune 24, 2025 | marketbeat.comForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B StudyJune 23, 2025 | businesswire.comForte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 33.5% in MayJune 17, 2025 | marketbeat.comTraders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)June 12, 2025 | marketbeat.comShort Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Increases By 18.5%June 5, 2025 | marketbeat.comForte Biosciences Stock Price, Quotes and Forecasts | NASDAQ:FBRX | BenzingaJune 1, 2025 | benzinga.comWoodline Partners LP Takes Position in Forte Biosciences, Inc. (NASDAQ:FBRX)May 26, 2025 | marketbeat.comTybourne Capital Management HK Ltd. Raises Stake in Forte Biosciences, Inc. (NASDAQ:FBRX)May 21, 2025 | marketbeat.comTD Cowen Remains a Buy on Forte Biosciences (FBRX)May 17, 2025 | theglobeandmail.comForte Biosciences price target lowered to $61 from $64 at ChardanApril 2, 2025 | markets.businessinsider.comIs Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?April 1, 2025 | finance.yahoo.comForte Biosciences (FBRX) Gets a Buy from TD CowenApril 1, 2025 | markets.businessinsider.comForte Biosciences, Inc. Announces Results and Provides Clinical UpdateMarch 31, 2025 | finance.yahoo.comForte Biosciences files $300M mixed securities shelfMarch 28, 2025 | markets.businessinsider.comForte Biosciences, Inc. (NASDAQ:FBRX) Short Interest UpdateFebruary 28, 2025 | marketbeat.comForte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX)February 20, 2025 | marketbeat.comOne Forte Biosciences Insider Raised Stake By 273% In Previous YearFebruary 19, 2025 | finance.yahoo.comForte Biosciences, Inc. to Present at Upcoming Investor MeetingsFebruary 3, 2025 | finance.yahoo.comTD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy RecommendationJanuary 22, 2025 | msn.com Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FBRX Media Mentions By Week FBRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBRX News Sentiment▼1.440.94▲Average Medical News Sentiment FBRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBRX Articles This Week▼61▲FBRX Articles Average Week Get the Latest News and Ratings for FBRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Forte Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies KOD News Today ATYR News Today AQST News Today ESPR News Today IVA News Today RAPP News Today CYRX News Today ZVRA News Today PRME News Today BCYC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBRX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBRX Stock Alerts